Skip to content

Clinical trials

Observational Recurrence trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Observational Country / region: Germany Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20143
20151
20161
20191
20212
20221
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
AGO Study Group1
AbbVie1
AstraZeneca1
Biogen1
Erasmus Medical Center1
Exscientia AI Limited1
Hannover Medical School1
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1
Max-Planck-Institute of Psychiatry1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence15
Leukemia, Myeloid, Acute2
Lymphoma, Follicular2
Lymphoma, Mantle-Cell2
Multiple Myeloma2
Ovarian Neoplasms2
Astrocytoma1
Atrial Fibrillation1
Atrial Flutter1
Atrial Remodeling1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.